---
$id: https://graph.org.ai/products/commodity/51144125
$type: Product
source: UNSPSC
code: "51144125"
title: "Mefenorex"
class: "51144100"
classTitle: "Stimulant or anorexiant amphetamines"
family: "51140000"
familyTitle: "Central nervous system drugs"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Mefenorex

**UNSPSC Code**: 51144125
**Class**: [Stimulant or anorexiant amphetamines](Stimulant or anorexiant amphetamines.mdx)
**Family**: [Central nervous system drugs](../Central nervous system drugs.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an anorexiant with the molecular formula C12H18ClN, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier (SRS UNII) K98M4N387W, chemically known as phenethylamine, n- (3-chloropropyl)-.alpha.-methyl-, hydrochloride but more generally known as mefenorex, which bears US NIH Compound Identifier 21777. European Medicines Agency schedules Mefenorex in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08706MIG. The term MEFENOREX is an International Non-Proprietary Name. World Health Organization schedules mefenorex in its Anatomical Therapeutic Chemical (ATC) Classification. MEFENOREX is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations, for tariff and trade purposes, schedule mefenorex under HS 29214600 and SITC kg. As of Q4 2014, MEFENOREX remains US FDA's Preferred Term for this commodity. Mefenorex bears US NLM identifiers UMLS ID C0065870 and NCI Concept Code C83915. SMILES: CC(CC1=CC=CC=C1)NCCCCL.

